McKesson Corporation $MCK Shares Sold by National Bank of Canada FI

15 Dec 2025, 05:50 by Jessica Moore · The Cerbat Gem

National Bank of Canada FI lowered its holdings in McKesson Corporation (NYSE:MCK – Free Report) by 40.6% in the second quarter, according to its most recent Form 13F filing with the SEC. The fund owned 105,343 shares of the company’s stock after selling 72,041 shares during the period. National Bank of Canada FI’s holdings in McKesson were worth $77,189,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently bought and sold shares of MCK. Solstein Capital LLC boosted its stake in shares of McKesson by 171.4% during the 2nd quarter. Solstein Capital LLC now owns 38 shares of the company’s stock valued at $28,000 after buying an additional 24 shares during the last quarter. GFG Capital LLC acquired a new position in McKesson during the 2nd quarter worth $30,000. Saudi Central Bank bought a new stake in shares of McKesson in the 1st quarter worth about $34,000. Loomis Sayles & Co. L P bought a new stake in shares of McKesson in the 2nd quarter worth about $39,000. Finally, Access Investment Management LLC acquired a new stake in shares of McKesson in the 2nd quarter valued at about $40,000. 85.07% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at McKesson

In other McKesson news, CAO Napoleon B. Rutledge, Jr. sold 329 shares of the firm’s stock in a transaction that occurred on Friday, November 7th. The shares were sold at an average price of $861.63, for a total value of $283,476.27. Following the sale, the chief accounting officer owned 328 shares in the company, valued at approximately $282,614.64. This trade represents a 50.08% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 0.08% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms recently commented on MCK. Zacks Research downgraded McKesson from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, November 25th. Citigroup lifted their target price on McKesson from $820.00 to $860.00 and gave the stock a “buy” rating in a research report on Wednesday, September 24th. TD Cowen upped their price target on McKesson from $830.00 to $864.00 and gave the company a “buy” rating in a research report on Wednesday, September 24th. Leerink Partners lifted their price objective on shares of McKesson from $785.00 to $850.00 and gave the stock an “outperform” rating in a report on Wednesday, September 24th. Finally, Bank of America increased their target price on shares of McKesson from $800.00 to $850.00 and gave the stock a “buy” rating in a report on Wednesday, September 24th. Two equities research analysts have rated the stock with a Strong Buy rating, twelve have issued a Buy rating and four have assigned a Hold rating to the stock. Based on data from MarketBeat.com, McKesson currently has a consensus rating of “Moderate Buy” and an average price target of $892.86.

Get Our Latest Stock Report on McKesson

McKesson Price Performance

Shares of MCK opened at $814.16 on Monday. The company has a market cap of $100.49 billion, a P/E ratio of 25.34, a PEG ratio of 1.34 and a beta of 0.38. The stock has a fifty day moving average price of $820.19 and a 200 day moving average price of $748.57. McKesson Corporation has a 12 month low of $558.13 and a 12 month high of $895.58.

McKesson (NYSE:MCK – Get Free Report) last posted its earnings results on Wednesday, November 5th. The company reported $9.86 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $8.84 by $1.02. McKesson had a negative return on equity of 248.14% and a net margin of 1.04%.The company had revenue of $103.15 billion for the quarter, compared to analysts’ expectations of $103.80 billion. During the same period last year, the business posted $7.07 earnings per share. The firm’s quarterly revenue was up 10.2% compared to the same quarter last year. As a group, research analysts anticipate that McKesson Corporation will post 32.77 earnings per share for the current year.

McKesson Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, January 2nd. Shareholders of record on Monday, December 1st will be paid a dividend of $0.82 per share. This represents a $3.28 dividend on an annualized basis and a yield of 0.4%. The ex-dividend date of this dividend is Monday, December 1st. McKesson’s payout ratio is presently 10.21%.

McKesson Company Profile

(Free Report)

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.